Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Digestive System Diseases × IDRX-42 × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1

Conditions

Gastrointestinal Stromal Tumors 2 Gastrointestinal Neoplasms 2 Neoplasm Metastasis 1 Gastrointestinal Diseases 1 Digestive System Diseases 1

Interventions

alectinib 1 Imatinib Mesylate 1 IDRX-42 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05489237 2025-11-17

First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors

IDRx Inc. - A GSK Company

Phase 1 Recruiting

GastrointestinalSarcoma

Digestive System Diseases, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Neoplasm Metastasis, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡